Strattera 40 mg kapsler, hårde Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

strattera 40 mg kapsler, hårde

orifarm a/s - atomoxetinhydrochlorid - kapsler, hårde - 40 mg

Strattera 60 mg kapsler, hårde Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

strattera 60 mg kapsler, hårde

orifarm a/s - atomoxetinhydrochlorid - kapsler, hårde - 60 mg

Strattera 80 mg kapsler, hårde Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

strattera 80 mg kapsler, hårde

orifarm a/s - atomoxetinhydrochlorid - kapsler, hårde - 80 mg

Strattera 80 mg kapsler, hårde Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

strattera 80 mg kapsler, hårde

europharma.dk aps - atomoxetinhydrochlorid - kapsler, hårde - 80 mg

Palexia Depot 150 mg depottabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

palexia depot 150 mg depottabletter

2care4 aps - tapentadolhydrochlorid - depottabletter - 150 mg

Paliperidon "Krka" 6 mg depottabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

paliperidon "krka" 6 mg depottabletter

krka d.d. novo mesto - paliperidon - depottabletter - 6 mg

Paliperidon "Krka" 9 mg depottabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

paliperidon "krka" 9 mg depottabletter

krka d.d. novo mesto - paliperidon - depottabletter - 9 mg

Carmustine "Macure" 100 mg pulver og solvens til koncentrat til infusionsvæske, opløsning Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

carmustine "macure" 100 mg pulver og solvens til koncentrat til infusionsvæske, opløsning

macure pharma aps - carmustin - pulver og solvens til koncentrat til infusionsvæske, opløsning - 100 mg

Byooviz Európai Unió - dán - EMA (European Medicines Agency)

byooviz

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologiske - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Tapentadol "Krka" 50 mg depottabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

tapentadol "krka" 50 mg depottabletter

krka d.d. novo mesto - tapentadolmaleathemihydrat - depottabletter - 50 mg